![PDF) Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017) PDF) Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017)](https://i1.rgstatic.net/publication/333785991_Invasive_meningococcal_disease_in_patients_with_complement_deficiencies_a_case_series_2008-2017/links/5d03e048a6fdcc39f11b5082/largepreview.png)
PDF) Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017)
![PDF) Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study PDF) Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study](https://i1.rgstatic.net/publication/309518892_Effectiveness_and_impact_of_a_reduced_infant_schedule_of_4CMenB_vaccine_against_group_B_meningococcal_disease_in_England_a_national_observational_cohort_study/links/58170ce608aedc7d896776cf/largepreview.png)
PDF) Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
![PDF) Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results PDF) Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results](https://i1.rgstatic.net/publication/348610587_Meningococcal_carriage_in_periods_of_high_and_low_invasive_meningococcal_disease_incidence_in_the_UK_comparison_of_UKMenCar1-4_cross-sectional_survey_results/links/6017d92da6fdcc071ba93548/largepreview.png)
PDF) Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
![PDF) Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015 PDF) Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015](https://i1.rgstatic.net/publication/334612728_Suspected_cluster_of_Neisseria_meningitidis_W_invasive_disease_in_an_elderly_care_home_do_new_laboratory_methods_aid_public_health_action_United_Kingdom_2015/links/5d3aeec692851cd046888439/largepreview.png)
PDF) Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015
![PDF) Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial PDF) Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial](https://i1.rgstatic.net/publication/348426408_Immunogenicity_of_the_UK_group_B_meningococcal_vaccine_4CMenB_schedule_against_groups_B_and_C_meningococcal_strains_Sched3_outcomes_of_a_multicentre_open-label_randomised_controlled_trial/links/5ffe6a20a6fdccdcb84d7da9/largepreview.png)
PDF) Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
![PDF) Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study PDF) Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study](https://i1.rgstatic.net/publication/324754773_Safety_of_multicomponent_meningococcal_group_B_vaccine_4CMenB_in_routine_infant_immunisation_in_the_UK_a_prospective_surveillance_study/links/5d137c55a6fdcc2462a8ff0d/largepreview.png)
PDF) Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study
![1174684252 NPI Number | NIK PARIKH MD PA | LINWOOD, NJ | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2022 1174684252 NPI Number | NIK PARIKH MD PA | LINWOOD, NJ | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2022](https://www.hipaaspace.com/medical_billing/coding/national_provider_identifier/codes/npi_1174684252.png)
1174684252 NPI Number | NIK PARIKH MD PA | LINWOOD, NJ | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2022
![Designing Client Organisations and Corporate Strategies [Short course] | The Bartlett School of Sustainable Construction - UCL – University College London Designing Client Organisations and Corporate Strategies [Short course] | The Bartlett School of Sustainable Construction - UCL – University College London](https://www.ucl.ac.uk/bartlett/construction/sites/bartlett_construction/files/styles/large_image/public/rob_jones.jpg?itok=I0765erc)